Introduction to Oslo Medtech. Innovation Health Care Conference Holmen Fjordhotell September 29 th, 2009

Transcription

1 Introduction to Oslo Medtech Innovation Health Care Conference Holmen Fjordhotell September 29 th, 2009

2 Background Oslo Univ. Hospital Akershus Univ. Hospital ~ Conducts 80 % of the medical research in Norway ~ M$ 170/yr for medical research ~1600 research manyears Medtech companies Small medtech companies One company one technology Long way to market Difficulties verifying technology and products Do not cooperate or work in networks ~ 27,000 hospital employees Huge potential for innovation Outcome???? Potential for more products, in an international market, more robust medtech industry

3 Cooperation in R&D, sharing and developing competence, building networks Oslo Univ. Hospital Medtech companies Akershus Univ. Hospital ~ Conducts 80 % of the medical research in Norway ~ M$ 170/yr for medical research ~1600 research manyears ~ 27,000 hospital employees Small medtech companies One company one technology Long way to market Difficulties verifying technology and products Do not cooperate or work in networks Outcome: New technology and medtech products and services, stronger international Norwegian medtech industry, better and more effective health service

4 Oslo Medtech - Main objectives Develop a strong cluster of medtech companies, Hospitals, R&D- and finance institutions in the Oslo region Purpose; Cooperation between medtech companies/r&d/hospitals Strengthen the technology base and competitiveness of the medtech companies Better and more effective medtech products in the health sector Attractive benefits for society: create more innovation, generate new products, services and companies, more effective health sector

5 Oslo Medtech pre-phase Pre-phase: Network initiative by Norwegian medtech companies - and Innovation Norway Drive in the initiative with the formation of Oslo University Hospital: Innovation a strategic goal Financing: Application to the ARENA-program, June 2009 Defend application for the ARENA-program committee Oct 1 st ARENA-status: Catlyst, competence, credibility Bring out the potential for innovation and new products in the medtech industry/hospitals

6 Current 34 participants in OMT Large medtech companies Medtech companies Hospitals / R&D TTOs / VC /reg. develop actors Cisco Systems AS Alertis Medical AS Neorad AS Akershus U-sykehus (Ahus) Akershus fylkeskommune Medistim ASA Biomolex AS Novlda AS Oslo Univ.sykehus herunder: Birkeland Innovasjon AS Tandberg AS Changetech AS Ostomycure AS OUS Ullevål Biomedisinsk Innovasjon AS Designit Oslo AS Posicom AS OUS Rikshospitalet Innovasjon Norge Oslo, Akershus, Østfold DP Com AS PubGene AS OUS Aker IT Fornebu Visjon AS Gamma Medica Ideas AS Sim Surgery AS SINTEF IKT MedCoast Scandinavia Healthy Pointers AS Volusense AS Medinnova AS MedSafe ASA WPR Medical AS NeoMed Management AS Med-storm Innovations AS Mole Genetics AS Viju Øst AS Skannex AS 6

7 Interim board Eirik Næss-Ulseth, CEO, PubGene AS (leader of the interim board) Kari Krogstad, CEO, Medistim ASA Kari Kværner, Director Research, OUS Ullevål Erik Fosse, Professor and CEO of the Interventional Centre, Oslo University Hospital - Rikshospitalet Stein Waaler, Deputy Managing Director, Akershus University Hospital Berit Sundby Avset, Research director, Microsystems and nanotechnology, SINTEF IKT Carl Christian Gilhuus-Moe, Partner, NeoMed Management AS Marius Øgaard, Director Network, IT Fornebu Visjon AS (facilitator) 7

8 Important event! Join us November 12th, 2009 noon to 1 pm at Akershus University Hospital for the formal Founding of Oslo Medtech Members: Norwegian medtech companies, hospitals, research institutions, finance and regional development actors in the field of medtech R&D

9 Want to become a member? post@oslomedtech.no Marius Øgaard, Director Networking: Kathrine Myhre, Interim Director OMT: